Skip to main content Accessibility help

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control

  • S. Bhattacharyya (a1), C. Iyegbe (a2), Z. Atakan (a1), R. Martin-Santos (a3), J. A. Crippa (a4), X. Xu (a2), S. Williams (a5), M. Brammer (a5), K. Rubia (a6), D. Prata (a1), D. A. Collier (a2) and P. K. McGuire (a1)...



What determines inter-individual variability to impairments in behavioural control that may underlie road-traffic accidents, and impulsive and violent behaviours occurring under the influence of cannabis, the most widely used illicit drug worldwide?


Employing a double-blind, repeated-measures design, we investigated the genetic and neural basis of variable sensitivity to cannabis-induced behavioural dyscontrol in healthy occasional cannabis users. Acute oral challenge with placebo or Δ9-tetrahydrocannabinol (THC), the main psychoactive ingredient in cannabis, was combined with functional magnetic resonance imaging, while participants performed a response inhibition task that involved inhibiting a pre-potent motor response. They were genotyped for rs1130233 single nucleotide polymorphisms (SNPs) of the protein kinase B (AKT1) gene.


Errors of inhibition were significantly (p = 0.008) increased following administration of THC in carriers of the A allele, but not in G allele homozygotes of the AKT1 rs1130233 SNP. The A allele carriers also displayed attenuation of left inferior frontal response with THC evident in the sample as a whole, while there was a modest enhancement of inferior frontal activation in the G homozygotes. There was a direct relationship (r = − 0.327, p = 0.045) between the behavioural effect of THC and its physiological effect in the inferior frontal gyrus, where AKT1 genotype modulated the effect of THC.


These results require independent replication and show that differing vulnerability to acute psychomotor impairments induced by cannabis depends on variation in a gene that influences dopamine function, and is mediated through modulation of the effect of cannabis on the inferior frontal cortex, that is rich in dopaminergic innervation and critical for psychomotor control.


Corresponding author

* Address for correspondence: S. Bhattacharyya, M.D., Ph.D., Department of Psychosis Studies and Psychosis Clinical Academic Group, King's College London, Institute of Psychiatry, 6th Floor, Main Building, PO Box 067, De Crespigny Park, London SE5 8AF, UK. (Email:


Hide All
Adams, IB, Martin, BR (1996). Cannabis: pharmacology and toxicology in animals and humans. Addiction 91, 15851614.
Aron, AR, Durston, S, Eagle, DM, Logan, GD, Stinear, CM, Stuphorn, V (2007). Converging evidence for a fronto-basal-ganglia network for inhibitory control of action and cognition. Journal of Neuroscience 27, 1186011864.
Beaulieu, JM, Gainetdinov, RR, Caron, MG (2007). The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacological Science 28, 166172.
Bhattacharyya, S, Atakan, Z, Martin-Santos, R, Crippa, JA, Kambeitz, J, Prata, D, Williams, S, Brammer, M, Collier, DA, McGuire, PK (2012 a). Preliminary report of biological basis of sensitivity to the effects of cannabis on psychosis: AKT1 and DAT1 genotype modulates the effects of Δ-9-tetrahydrocannabinol on midbrain and striatal function. Molecular Psychiatry 17, 11521155.
Bhattacharyya, S, Crippa, JA, Allen, P, Martin-Santos, R, Borgwardt, S, Fusar-Poli, P, Rubia, K, Kambeitz, J, O'Carroll, C, Seal, ML, Giampietro, V, Brammer, M, Zuardi, AW, Atakan, Z, McGuire, PK (2012 b). Induction of psychosis by Δ9-tetrahydrocannabinol reflects modulation of prefrontal and striatal function during attentional salience processing. Archives of General Psychiatry 69, 2736.
Bhattacharyya, S, Crippa, JA, Martin-Santos, R, Winton-Brown, T, Fusar-Poli, P (2009 a). Imaging the neural effects of cannabinoids: current status and future opportunities for psychopharmacology. Current Pharmaceutical Design 15, 26032614.
Bhattacharyya, S, Fusar-Poli, P, Borgwardt, S, Martin-Santos, R, Nosarti, C, O'Carroll, C, Allen, P, Seal, ML, Fletcher, PC, Crippa, JA, Giampietro, V, Mechelli, A, Atakan, Z, McGuire, P (2009 b). Modulation of mediotemporal and ventrostriatal function in humans by Δ9-tetrahydrocannabinol: a neural basis for the effects of Cannabis sativa on learning and psychosis. Archives of General Psychiatry 66, 442451.
Bhattacharyya, S, Morrison, PD, Fusar-Poli, P, Martin-Santos, R, Borgwardt, S, Winton-Brown, T, Nosarti, C, O'Carroll, CM, Seal, M, Allen, P, Mehta, MA, Stone, JM, Tunstall, N, Giampietro, V, Kapur, S, Murray, RM, Zuardi, AW, Crippa, JA, Atakan, Z, McGuire, PK (2010). Opposite effects of Δ-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology 35, 764774.
Blasi, G, Napolitano, F, Ursini, G, Taurisano, P, Romano, R, Caforio, G, Fazio, L, Gelao, B, Di Giorgio, A, Iacovelli, L, Sinibaldi, L, Popolizio, T, Usiello, A, Bertolino, A (2011). DRD2/AKT1 interaction on D2 c-AMP independent signaling, attentional processing, and response to olanzapine treatment in schizophrenia. Proceedings of the National Academy of Sciences USA 108, 11581163.
Borgwardt, SJ, Allen, P, Bhattacharyya, S, Fusar-Poli, P, Crippa, JA, Seal, ML, Fraccaro, V, Atakan, Z, Martin-Santos, R, O'Carroll, C, Rubia, K, McGuire, PK (2008). Neural basis of Δ-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry 64, 966973.
Bossong, MG, van Berckel, BN, Boellaard, R, Zuurman, L, Schuit, RC, Windhorst, AD, van Gerven, JM, Ramsey, NF, Lammertsma, AA, Kahn, RS (2009). Δ9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology 34, 759766.
Casey, BJ, Trainor, R, Orendi, JL, Schubert, AB, Nystrom, LE, Giedd, JN, Castellanos, FX, Haxby, JV, Noll, DC, Cohen, JD, Forman, SD, Dahl, RE, Rapoport, JL (1997). A developmental functional MRI study of prefrontal activation during performance of a go/no-go task. Journal of Cognitive Neuroscience 9, 835847.
Chamberlain, SR, Sahakian, BJ (2007). The neuropsychiatry of impulsivity. Current Opinion in Psychiatry 20, 255261.
Chen, J, Paredes, W, Lowinson, JH, Gardner, EL (1990 a). Δ9-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex. European Journal of Pharmacology 190, 259262.
Chen, JP, Paredes, W, Li, J, Smith, D, Lowinson, J, Gardner, EL (1990 b). Δ9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology (Berlin) 102, 156162.
Compton, WM, Grant, BF, Colliver, JD, Glantz, MD, Stinson, FS (2004). Prevalence of marijuana use disorders in the United States: 1991–1992 and 2001–2002. Journal of the American Medical Association 291, 21142121.
Curran, HV, Brignell, C, Fletcher, S, Middleton, P, Henry, J (2002). Cognitive and subjective dose–response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berlin) 164, 6170.
Dale, AM (1999). Optimal experimental design for event-related fMRI. Human Brain Mapping 8, 109114.
Di Forti, M, Iyegbe, C, Sallis, H, Kolliakou, A, Falcone, MA, Paparelli, A, Sirianni, M, La Cascia, C, Stilo, SA, Marques, TR, Handley, R, Mondelli, V, Dazzan, P, Pariante, C, David, AS, Morgan, C, Powell, J, Murray, RM (2012). Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biological Psychiatry 72, 811816.
Duncan, SC, Strycker, LA, Duncan, TE (1999). Exploring associations in developmental trends of adolescent substance use and risky sexual behavior in a high-risk population. Journal of Behavioral Medicine 22, 2134.
Durston, S, Thomas, KM, Worden, MS, Yang, Y, Casey, BJ (2002). The effect of preceding context on inhibition: an event-related fMRI study. NeuroImage 16, 449453.
Eagle, DM, Bari, A, Robbins, TW (2008). The neuropsychopharmacology of action inhibition: cross-species translation of the stop-signal and go/no-go tasks. Psychopharmacology (Berlin) 199, 439456.
Egan, MF, Goldberg, TE, Kolachana, BS, Callicott, JH, Mazzanti, CM, Straub, RE, Goldman, D, Weinberger, DR (2001). Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences USA 98, 69176922.
European Monitoring Centre for Drugs and Drug Addiction (2010). 2010 Annual report on the state of the drugs problem in Europe ( Accessed 22 January 2014.
Fassbender, C, Murphy, K, Foxe, JJ, Wylie, GR, Javitt, DC, Robertson, IH, Garavan, H (2004). A topography of executive functions and their interactions revealed by functional magnetic resonance imaging. Brain Research Cognitive Brain Research 20, 132143.
Fergusson, DM, Horwood, LJ (1997). Early onset cannabis use and psychosocial adjustment in young adults. Addiction 92, 279296.
Fillmore, MT, Blackburn, JS, Harrison, EL (2008). Acute disinhibiting effects of alcohol as a factor in risky driving behavior. Drug and Alcohol Dependence 95, 97106.
Freeman, B, Smith, N, Curtis, C, Huckett, L, Mill, J, Craig, IW (2003). DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behavior Genetics 33, 6772.
French, ED, Dillon, K, Wu, X (1997). Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra. Neuroreport 8, 649652.
Friedman, AS, Glassman, K, Terras, BA (2001). Violent behavior as related to use of marijuana and other drugs. Journal of Addictive Diseases 20, 4972.
Friedman, AS, Kramer, S, Kreisher, C, Granick, S (1996). The relationships of substance abuse to illegal and violent behavior, in a community sample of young adult African American men and women (gender differences). Journal of Substance Abuse 8, 379402.
Garavan, H, Ross, TJ, Stein, EA (1999). Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proceedings of the National Academy of Sciences USA 96, 83018306.
Giovannetti, E, Zucali, PA, Peters, GJ, Cortesi, F, D'Incecco, A, Smit, EF, Falcone, A, Burgers, JA, Santoro, A, Danesi, R, Giaccone, G, Tibaldi, C (2010). Association of polymorphisms in AKT1 and EGFR with clinical outcome and toxicity in non-small cell lung cancer patients treated with gefitinib. Molecular Cancer Therapeutics 9, 581593.
Gómez del Pulgar, T, Velasco, G, Guzmán, M (2000). The CB1 cannabinoid receptor is coupled to the activation of protein kinase B/Akt. Biochemical Journal 347, 369373.
Hall, W, Degenhardt, L (2007). Prevalence and correlates of cannabis use in developed and developing countries. Current Opinion in Psychiatry 20, 393397.
Hall, W, Degenhardt, L (2009). Adverse health effects of non-medical cannabis use. Lancet 374, 13831391.
Hall, W, Solowij, N (1998). Adverse effects of cannabis. Lancet 352, 16111616.
Hariri, AR, Weinberger, DR (2003). Imaging genomics. British Medical Bulletin 65, 259270.
Harris, SL, Gil, G, Robins, H, Hu, W, Hirshfield, K, Bond, E, Bond, G, Levine, AJ (2005). Detection of functional single-nucleotide polymorphisms that affect apoptosis. Proceedings of the National Academy of Sciences USA 102, 1629716302.
Howes, OD, Kapur, S (2009). The dopamine hypothesis of schizophrenia: version III – the final common pathway. Schizophrenia Bulletin 35, 549562.
Kawashima, R, Satoh, K, Itoh, H, Ono, S, Furumoto, S, Gotoh, R, Koyama, M, Yoshioka, S, Takahashi, T, Takahashi, K, Yanagisawa, T, Fukuda, H (1996). Functional anatomy of GO/NO-GO discrimination and response selection – a PET study in man. Brain Research 728, 7989.
Kingree, JB, Betz, H (2003). Risky sexual behavior in relation to marijuana and alcohol use among African-American, male adolescent detainees and their female partners. Drug and Alcohol Dependence 72, 197203.
Krams, M, Rushworth, MF, Deiber, MP, Frackowiak, RS, Passingham, RE (1998). The preparation, execution and suppression of copied movements in the human brain. Experimental Brain Research 120, 386398.
Lai, WS, Xu, B, Westphal, KG, Paterlini, M, Olivier, B, Pavlidis, P, Karayiorgou, M, Gogos, JA (2006). Akt1 deficiency affects neuronal morphology and predisposes to abnormalities in prefrontal cortex functioning. Proceedings of the National Academy of Sciences USA 103, 1690616911.
Lane, SD, Cherek, DR, Tcheremissine, OV, Lieving, LM, Pietras, CJ (2005). Acute marijuana effects on human risk taking. Neuropsychopharmacology 30, 800809.
Li, CS, Huang, C, Constable, RT, Sinha, R (2006). Imaging response inhibition in a stop-signal task: neural correlates independent of signal monitoring and post-response processing. Journal of Neuroscience 26, 186192.
Macleod, J, Oakes, R, Copello, A, Crome, I, Egger, M, Hickman, M, Oppenkowski, T, Stokes-Lampard, H, Davey Smith, G (2004). Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 363, 15791588.
Martin-Santos, R, Fagundo, AB, Crippa, JA, Atakan, Z, Bhattacharyya, S, Allen, P, Fusar-Poli, P, Borgwardt, S, Seal, M, Busatto, GF, McGuire, P (2010). Neuroimaging in cannabis use: a systematic review of the literature. Psychological Medicine 40, 383398.
McDonald, J, Schleifer, L, Richards, JB, de Wit, H (2003). Effects of THC on behavioral measures of impulsivity in humans. Neuropsychopharmacology 28, 13561365.
McLellan, AT, Luborsky, L, Woody, GE, O'Brien, CP (1980). An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. Journal of Nervous and Mental Disease 168, 2633.
Menon, V, Adleman, NE, White, CD, Glover, GH, Reiss, AL (2001). Error-related brain activation during a Go/NoGo response inhibition task. Human Brain Mapping 12, 131143.
National Centre for Natural Products Research (2009). Quarterly report: potency monitoring project: Report 104 ( Accessed 22 January 2014.
Nelson, HE (1982). National Adult Reading Test (NART): Test Manual. NFER-Nelson: Windsor.
Ohlsson, A, Lindgren, JE, Wahlen, A, Agurell, S, Hollister, LE, Gillespie, HK (1980). Plasma Δ-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clinical Pharmacology and Therapeutics 28, 409416.
Ozaita, A, Puighermanal, E, Maldonado, R (2007). Regulation of PI3 K/Akt/GSK-3 pathway by cannabinoids in the brain. Journal of Neurochemistry 102, 11051114.
Pertwee, RG (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin. British Journal of Pharmacology 153, 199215.
Pietilainen, OP, Paunio, T, Loukola, A, Tuulio-Henriksson, A, Kieseppa, T, Thompson, P, Toga, AW, van Erp, TG, Silventoinen, K, Soronen, P, Hennah, W, Turunen, JA, Wedenoja, J, Palo, OM, Silander, K, Lonnqvist, J, Kaprio, J, Cannon, TD, Peltonen, L (2009). Association of AKT1 with verbal learning, verbal memory, and regional cortical gray matter density in twins. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 150B, 683692.
Potter, DJ, Clark, P, Brown, MB (2008). Potency of Δ9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. Journal of Forensic Sciences 53, 9094.
Ramaekers, JG, Berghaus, G, van Laar, M, Drummer, OH (2004). Dose related risk of motor vehicle crashes after cannabis use. Drug and Alcohol Dependence 73, 109119.
Ramaekers, JG, Kauert, G, Theunissen, EL, Toennes, SW, Moeller, MR (2009). Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. Journal of Psychopharmacology 23, 266277.
Ramaekers, JG, Kauert, G, van Ruitenbeek, P, Theunissen, EL, Schneider, E, Moeller, MR (2006). High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacology 31, 22962303.
Ramaekers, JG, Robbe, HW, O'Hanlon, JF (2000). Marijuana, alcohol and actual driving performance. Human Psychopharmacology 15, 551558.
Resnick, MD, Bearman, PS, Blum, RW, Bauman, KE, Harris, KM, Jones, J, Tabor, J, Beuhring, T, Sieving, RE, Shew, M, Ireland, M, Bearinger, LH, Udry, JR (1997). Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. Journal of the American Medical Association 278, 823832.
Rubia, K, Lee, F, Cleare, AJ, Tunstall, N, Fu, CH, Brammer, M, McGuire, P (2005 a). Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berlin) 179, 791803.
Rubia, K, Russell, T, Overmeyer, S, Brammer, MJ, Bullmore, ET, Sharma, T, Simmons, A, Williams, SC, Giampietro, V, Andrew, CM, Taylor, E (2001). Mapping motor inhibition: conjunctive brain activations across different versions of go/no-go and stop tasks. NeuroImage 13, 250261.
Rubia, K, Smith, AB, Brammer, MJ, Toone, B, Taylor, E (2005 b). Abnormal brain activation during inhibition and error detection in medication-naive adolescents with ADHD. American Journal of Psychiatry 162, 10671075.
Rubia, K, Smith, AB, Taylor, E, Brammer, M (2007). Linear age-correlated functional development of right inferior fronto-striato-cerebellar networks during response inhibition and anterior cingulate during error-related processes. Human Brain Mapping 28, 11631177.
Rubia, K, Smith, AB, Woolley, J, Nosarti, C, Heyman, I, Taylor, E, Brammer, M (2006). Progressive increase of frontostriatal brain activation from childhood to adulthood during event-related tasks of cognitive control. Human Brain Mapping 27, 973993.
Salvucci, DD (2006). Modeling driver behavior in a cognitive architecture. Human Factors 48, 362380.
Sánchez, MG, Ruiz-Llorente, L, Sánchez, AM, Diaz-Laviada, I (2003). Activation of phosphoinositide 3-kinase/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction. Cellular Signalling 15, 851859.
Schneider, NG, Jarvik, ME (1984). Time course of smoking withdrawal symptoms as a function of nicotine replacement. Psychopharmacology (Berlin) 82, 143144.
Seamans, JK, Yang, CR (2004). The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Progress in Neurobiology 74, 158.
Skosnik, PD, Spatz-Glenn, L, Park, S (2001). Cannabis use is associated with schizotypy and attentional disinhibition. Schizophrenia Research 48, 8392.
Stokes, PR, Egerton, A, Watson, B, Reid, A, Breen, G, Lingford-Hughes, A, Nutt, DJ, Mehta, MA (2010). Significant decreases in frontal and temporal [11C]-raclopride binding after THC challenge. NeuroImage 52, 15211527.
Tan, HY, Chen, AG, Chen, Q, Browne, LB, Verchinski, B, Kolachana, B, Zhang, F, Apud, J, Callicott, JH, Mattay, VS, Weinberger, DR (2012). Epistatic interactions of AKT1 on human medial temporal lobe biology and pharmacogenetic implications. Molecular Psychiatry 17, 10071016.
Tan, HY, Nicodemus, KK, Chen, Q, Li, Z, Brooke, JK, Honea, R, Kolachana, BS, Straub, RE, Meyer-Lindenberg, A, Sei, Y, Mattay, VS, Callicott, JH, Weinberger, DR (2008). Genetic variation in AKT1 is linked to dopamine-associated prefrontal cortical structure and function in humans. Journal of Clinical Investigation 118, 22002208.
Tanda, G, Pontieri, FE, Di Chiara, G (1997). Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science 276, 20482050.
United Nations Office on Drugs and Crime (2010). World Drug Report 2010. United Nations Publication, Sales No. E.10.XI. 13 ( Accessed 22 January 2014.
van Winkel, R, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (2011 a). Family-based analysis of genetic variation underlying psychosis-inducing effects of cannabis: sibling analysis and proband follow-up. Archives of General Psychiatry 68, 148157.
van Winkel, R, van Beveren, NJ, Simons, C (2011 b). AKT1 moderation of cannabis-induced cognitive alterations in psychotic disorder. Neuropsychopharmacology 36, 25292537.
Voruganti, LN, Slomka, P, Zabel, P, Mattar, A, Awad, AG (2001). Cannabis induced dopamine release: an in-vivo SPECT study. Psychiatry Research 107, 173177.
Watts, WD, Wright, LS (1990). The relationship of alcohol, tobacco, marijuana, and other illegal drug use to delinquency among Mexican-American, black, and white adolescent males. Adolescence 25, 171181.
Weinstein, A, Brickner, O, Lerman, H, Greemland, M, Bloch, M, Lester, H, Chisin, R, Mechoulam, R, Bar-Hamburger, R, Freedman, N, Even-Sapir, E (2008 a). Brain imaging study of the acute effects of Δ9-tetrahydrocannabinol (THC) on attention and motor coordination in regular users of marijuana. Psychopharmacology (Berlin) 196, 119131.
Weinstein, A, Brickner, O, Lerman, H, Greemland, M, Bloch, M, Lester, H, Chisin, R, Sarne, Y, Mechoulam, R, Bar-Hamburger, R, Freedman, N, Even-Sapir, E (2008 b). A study investigating the acute dose–response effects of 13 mg and 17 mg Δ9-tetrahydrocannabinol on cognitive–motor skills, subjective and autonomic measures in regular users of marijuana. Journal of Psychopharmacology 22, 441451.
White, HR, Loeber, R, Stouthamer-Loeber, M, Farrington, DP (1999). Developmental associations between substance use and violence. Development and Psychopathology 11, 785803.


Type Description Title
Supplementary materials

Bhattacharyya Supplementary Material
Supplementary Material

 Word (101 KB)
101 KB

Protein kinase B (AKT1) genotype mediates sensitivity to cannabis-induced impairments in psychomotor control

  • S. Bhattacharyya (a1), C. Iyegbe (a2), Z. Atakan (a1), R. Martin-Santos (a3), J. A. Crippa (a4), X. Xu (a2), S. Williams (a5), M. Brammer (a5), K. Rubia (a6), D. Prata (a1), D. A. Collier (a2) and P. K. McGuire (a1)...


Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed